Jorge G Siro Herrero

Title: Jorge G Siro Herrero: Innovator in Phosphodiesterase Inhibitors

Introduction

Jorge G Siro Herrero is a notable inventor based in Calà d'Henares, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as phosphodiesterase 4 inhibitors. His work is crucial in advancing treatments for various medical conditions.

Latest Patents

Jorge holds a patent for "Phthalazine derivatives as phosphodiesterase 4 inhibitors." This patent includes compounds of formula (I) wherein B is alkylene, amino, CONH, or a bond. The compounds feature Cy, which is optionally substituted phenyl or heteroaryl, and R, which can be H, phenyl, or (C)alkyl optionally substituted. Additionally, R can be (C)alkyl or polyfluoro(C)-alkyl, and R can be (C)cycloalkyl optionally containing an oxygen atom and optionally substituted. The N→O derivatives and pharmaceutically acceptable salts thereof are identified as PDE 4 and TNFα inhibitors. This innovation has the potential to impact therapeutic strategies significantly.

Career Highlights

Jorge is currently associated with Zambon Group S.p.a., where he continues to work on innovative pharmaceutical solutions. His expertise in medicinal chemistry and drug development has positioned him as a valuable asset in the industry.

Collaborations

Throughout his career, Jorge has collaborated with notable colleagues, including Mauro Napoletano and Gabriele Pietro Norcini. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Jorge G Siro Herrero is a distinguished inventor whose work in phosphodiesterase inhibitors showcases his commitment to advancing medical science. His contributions are vital for the development of new therapeutic options.